Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
14955
Title:
Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 update and consensus statement from the Canadian Pain Society
Fulltext:
View PDF
Publication/Review date:
2015-Feb 
Producers:
Canadian Pain Society

Bibliographic Source

Journal Citation:
Pain Res Manage 2015;20(1):46-7.
Pages/Size:
2  Page(s)
References:
1

Subject Information

Specialties:
Community and preventive medicine,
Conditions:
Shingles;
Domains:
Preventive
Target Populations:
Elderly, Adult
Target Gender:
Unknown
MeSH:
Immunocompromised Host; Neuralgia; Risk Factors; Herpes Zoster Vaccine; Herpes Zoster;

Copyright:

The copyright of this guideline and its companion documents belongs to: Pulsus Group Inc.

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​